计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| U351248-5mg |
5mg |
现货 ![]() |
| |
| U351248-10mg |
10mg |
现货 ![]() |
| |
| U351248-25mg |
25mg |
现货 ![]() |
| |
| U351248-50mg |
50mg |
现货 ![]() |
| |
| U351248-100mg |
100mg |
现货 ![]() |
| |
| U351248-200mg |
200mg |
现货 ![]() |
|
| 别名 | 3'-氨基甲酰基-6-羟基-[1,1'-联苯]-3-基 环己基氨基甲酸酯 |
|---|---|
| 英文别名 | cyclohexylcarbamic acid 3'-carbamoyl-6-hydroxybiphenyl-3-yl ester | DTXSID801018151 | BDBM50437227 | MS-25529 | [3-(3-carbamoylphenyl)-4-hydroxyphenyl] N-cyclohexylcarbamate | 3'-(Aminocarbonyl)-6-hydroxy[1,1'-biphenyl]-3-yl N-cyclohexylcarbamate | AC-365 |
| 规格或纯度 | Moligand™, ≥98% |
| 英文名称 | URB 937 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 抑制剂 |
| 作用机制 | 脂肪酸酰胺水解酶抑制剂 |
| 产品介绍 |
URB937 是口服有效的、外周限制的 FAAH 抑制剂,IC50 值为 26.8 nM,可增加 anandamide 水平。URB937 不能影响脑内 FAAH 水平 (无法透过血脑屏障) Product description URB937 is an orally active and peripherally restricted FAAH inhibitor (IC50=26.8 nM) and increases anandamide levels. URB937 fails to affect FAAH activity in the brain (not penetrate the blood-brain barrier). |
| 纯度 | ≥98% |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| PubChem SID | 504771192 |
|---|---|
| 分子类型 | 小分子 |
| IIUPAC Name | [3-(3-carbamoylphenyl)-4-hydroxyphenyl] N-cyclohexylcarbamate |
| INCHI | 1S/C20H22N2O4/c21-19(24)14-6-4-5-13(11-14)17-12-16(9-10-18(17)23)26-20(25)22-15-7-2-1-3-8-15/h4-6,9-12,15,23H,1-3,7-8H2,(H2,21,24)(H,22,25) |
| InChi Key | CMEQHOXCIGFZNJ-UHFFFAOYSA-N |
| Smiles | C1CCC(CC1)NC(=O)OC2=CC(=C(C=C2)O)C3=CC(=CC=C3)C(=O)N |
| Isomeric SMILES | C1CCC(CC1)NC(=O)OC2=CC(=C(C=C2)O)C3=CC(=CC=C3)C(=O)N |
| PubChem CID | 53394762 |
| 分子量 | 354.4 |
| 分子量 | 354.400 g/mol |
|---|---|
| XLogP3 | 3.500 |
| 氢键供体数Hydrogen Bond Donor Count | 3 |
| 氢键受体数Hydrogen Bond Acceptor Count | 4 |
| 可旋转键计数Rotatable Bond Count | 5 |
| 精确质量Exact Mass | 354.158 Da |
| 单同位素质量Monoisotopic Mass | 354.158 Da |
| 拓扑极表面积Topological Polar Surface Area | 102.000 Ų |
| 重原子数Heavy Atom Count | 26 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 492.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| WGK Germany | 3 |
|---|---|
| RIDADR | NONHforallmodesoftransport |
| 1. Slivicki RA, Xu Z, Mali SS, Hohmann AG. (2019) Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase suppress the development and maintenance of paclitaxel-induced neuropathic pain without producing tolerance or physical dependence in vivo and synergize with paclitaxel to reduce tumor cell line viability in vitro.. Pharmacol Res, 142 (267-282). [PMID:30739035] |